AHEAD OF ACIP VOTE ON WHETHER TO WITHDRAW RECOMMENDATION FOR J&J VACCINE, ICAN AGAIN WRITES TO CDC AND FDA REGARDING CONCERN J&J VACCINE CHANGES DNA IN THE VACCINEE
ICAN SENDS CRITICAL AND TIMELY INFORMATION TO EACH MEMBER OF ACIP AHEAD OF THEIR VOTE THAT WILL DETERMINE THE FATE OF THE J&J/JANSSEN COVID-19 VACCINE
EMERGENCY PETITION TO HALT CLINICAL TRIAL OF ASTRAZENECA AND OXFORD’S COVID-19 VACCINE UNLESS ALL ADVERSE REACTIONS ARE TRACKED IN A PLACEBO-CONTROLLED CLINICAL TRIAL
